Key result
Statin withdrawal during NSTEMI hospitalization is linked to higher hospital mortality versus continuation.
Why the study?
The impact of early withdrawal of statin therapy during hospitalization for non-ST-segment elevation myocardial infarction on patient outcomes was uncertain.
Does withdrawal of statin therapy increase hospital morbidity and mortality in patients with non-ST-segment elevation myocardial infarction?
Observational (n=68,506)
Yes
Does withdrawal of statin therapy increase hospital morbidity and mortality in patients with non-ST-segment elevation myocardial infarction?
Withdrawal of statin therapy in the first 24 hours of hospitalization for non-ST-segment elevation myocardial infarction is associated with worse hospital outcomes, including increased mortality.
No takes yet. Share an insight, caveat, or question.
May warrant avoiding statin withdrawal in NSTEMI; leaves open causality and need for RCTs.
Frederick A. Spencer (2004) conducted an observational in Non-ST-segment elevation myocardial infarction (n=68,506). Withdrawal of statin therapy vs. Continued statin therapy or no prior statin therapy was evaluated on Hospital death. Withdrawal of statin therapy (occurring in 35.1% of prior users) during NSTEMI hospitalization was associated with a statistically significant increased risk of hospital death versus continuation.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: